Kidney function and systolic blood pressure new insights from cystatin C: Data from the Heart and Soul Study

被引:39
|
作者
Peralta, Carmen A.
Whooley, Mary A.
Ix, Joachim H.
Shlipak, Michael G.
机构
[1] Va Med CXtr, Gen Internal Med Sect, San Francisco, CA 94124 USA
[2] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
kidney; hypertension; cystatin C; systolic blood pressure;
D O I
10.1016/j.amjhyper.2006.02.007
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Control of hypertension is paramount in treating chronic kidney disease. The relationship between kidney function and blood pressure (BP) components has been studied in persons with diagnosed CKD, diabetes, or hypertension. Whether kidney function in the normal range is associated with systolic BP (SBP), diastolic BP (DBP), and pulse pressure is unclear. Methods: We evaluated the association between kidney function and each BP component using cystatin C and 24-h creatinine clearance (CrCl) among 906 participants in the Heart and Soul Study. Results: We observed that SBP was linearly associated with cystatin C concentrations (1.19 +/- 0.55 mm Hg increase per 0.4 mg/L cystatin C, P = .03) across the range of kidney functions. In contrast, using CrCl, SBP was significantly associated with kidney function only in subjects with CrCl < 60 mL/min (6.4 +/- 2.13 mm Hg increase per 28 mL/min, P = .003) but not > 60 mL/min (0.36 +/- 0.77 mm Hg per 28 mL/min, P = .64). Slopes differed significantly (for spline term P = .001). We found that DBP was not associated with cystatin C (0.34 +/- 0.40 mm Hg per 0.4 mg/L cystatin, P = .39) or CrCl (0.62 +/- 0.44 mm Hg per 28 mL/min clearance, P = .16). Pulse pressure was linearly associated with cystatin C (1.28 +/- 0.55 mm Hg per 0.4 mg/L cystatin, P = .02) and with CrCl < 60 mL/min (7.27 +/- 2.16 mm Hg per 28 mL/min, P = .001). Conclusions: Both SBP and pulse pressure were significantly associated with kidney function across a wide range of cystatin C concentrations, even in subjects with presumably normal kidney function, by creatinine-based measures. Cystatin C may provide new insights into the association of CKD and hypertension, a relationship that may be an underappreciated barrier to hypertension control.
引用
收藏
页码:939 / 946
页数:8
相关论文
共 50 条
  • [31] New insights into angiotensin receptor actions: from blood pressure to aging
    Stegbauer, Johannes
    Coffman, Thomas M.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (01) : 84 - 88
  • [32] Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women
    Malmgren, Linnea
    McGuigan, Fiona E.
    Christensson, Anders
    Akesson, Kristina E.
    NEPHRON, 2020, 144 (06) : 290 - 298
  • [33] Burden of Hypertensive Heart Disease and High Systolic Blood Pressure in Australia from 1990 to 2019: Results From the Global Burden of Diseases Study
    Islam, Sheikh Mohammad Shariful
    Daryabeygi-Khotbehsara, Reza
    Ghaffari, Mohammad Payam
    Uddin, Riaz
    Gao, Lan
    Xu, Xiaoyue
    Siddiqui, Muhammad Umer
    Livingstone, Katherine M.
    Siopis, George
    Sarrafzadegan, Nizal
    Schlaich, Markus
    Maddison, Ralph
    Huxley, Rachel
    Schutte, Aletta E.
    HEART LUNG AND CIRCULATION, 2023, 32 (10) : 1178 - 1188
  • [34] Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial
    Li, Sitong
    Jiang, Chao
    Wang, Yufeng
    Lai, Yiwei
    Zhao, Manlin
    Li, Qifan
    Bai, Yu
    Dai, Wenli
    Guo, Qi
    He, Liu
    Guo, Xueyuan
    Wang, Wei
    Li, Songnan
    Liu, Nian
    Jiang, Chenxi
    Tang, Ribo
    Sang, Caihua
    Long, Deyong
    Du, Xin
    Dong, Jianzeng
    Anderson, Craig S.
    Ma, Changsheng
    HYPERTENSION, 2023, 80 (08) : 1628 - 1636
  • [35] Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort
    Chiang, Heng-Pin
    Lee, Jia-Jung
    Chiu, Yi-Wen
    Tsai, Jer-Chia
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (11) : 1396 - 1407
  • [36] Hypertension Management in Chronic Kidney Disease and Diabetes Lessons from the Systolic Blood Pressure Intervention Trial
    Thomas, George
    CARDIOLOGY CLINICS, 2019, 37 (03) : 307 - +
  • [37] Longitudinal Blood Pressure Changes and Kidney Function Decline in Persons Without Chronic Kidney Disease: Findings From the MESA Study
    Judson, Gregory L.
    Rubinsky, Anna D.
    Shlipak, Michael G.
    Katz, Ronit
    Kramer, Holly
    Jacobs, David R., Jr.
    Odden, Michelle C.
    Peralta, Carmen A.
    AMERICAN JOURNAL OF HYPERTENSION, 2018, 31 (05) : 600 - 608
  • [38] Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study
    Keller, Till
    Messow, Claudia Martina
    Lubos, Edith
    Nicaud, Viviane
    Wild, Philipp S.
    Rupprecht, Hans J.
    Bickel, Christoph
    Tzikas, Stergios
    Peetz, Dirk
    Lackner, Karl J.
    Tiret, Laurence
    Muenzel, Thomas
    Blankenberg, Stefan
    Schnabel, Renate B.
    EUROPEAN HEART JOURNAL, 2009, 30 (03) : 314 - 320
  • [39] Systolic blood pressure is associated with abnormal alterations in brain cortical structure: Evidence from a Mendelian randomization study
    Ye, Ziliang
    Zeng, Qing
    Ning, Limeng
    Huang, Wanzhong
    Su, Qiang
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 120 : 92 - 98
  • [40] Associations of Insulin Resistance With Systolic and Diastolic Blood Pressure A Study From the HCHS/SOL
    Quesada, Odayme
    Claggett, Brian
    Rodriguez, Fatima
    Cai, Jianwen
    Moncrieft, Ashley E.
    Garcia, Karin
    Del Rios Rivera, Marina
    Hanna, David B.
    Daviglus, Martha L.
    Talavera, Gregory A.
    Bairey Merz, C. Noel
    Solomon, Scott D.
    Cheng, Susan
    Bello, Natalie A.
    HYPERTENSION, 2021, 78 (03) : 716 - 725